These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14593750)

  • 41. Tiagabine in glial tumors.
    Striano S; Striano P; Boccella P; Nocerino C; Bilo L
    Epilepsy Res; 2002 Mar; 49(1):81-5. PubMed ID: 11948010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacology and clinical experience with tiagabine.
    Schachter SC
    Expert Opin Pharmacother; 2001 Jan; 2(1):179-87. PubMed ID: 11336578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Open multicenter study of the effectiveness and safety of gabitril in epileptic patients with partial seizures].
    Czapiński P; Jedrzejczak J; Kozik A; Sobaniec W; Wendorff J; Grygolec P
    Neurol Neurochir Pol; 2000; 34 Suppl 7():35-53. PubMed ID: 11253490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?
    Somerville ER
    Neurology; 2002 Jul; 59(1):79-83. PubMed ID: 12105311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment.
    Sackellares JC; Krauss G; Sommerville KW; Deaton R
    Epilepsia; 2002 Apr; 43(4):394-8. PubMed ID: 11952769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of the antiepileptic drug tiagabine.
    Schachter SC
    Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [symbol: see text] Tiagabine: add-on treatment for partial seizures.
    Drug Ther Bull; 2000 Jun; 38(6):47-8. PubMed ID: 10912300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epilepsy in the elderly: the use of tiagabine.
    Pedersen B
    Epilepsia; 2001; 42 Suppl 3():52-4. PubMed ID: 11520325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
    Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
    Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tiagabine-induced absence status in idiopathic generalized epilepsy.
    Knake S; Hamer HM; Schomburg U; Oertel WH; Rosenow F
    Seizure; 1999 Aug; 8(5):314-7. PubMed ID: 10486298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.
    Samara EE; Gustavson LE; El-Shourbagy T; Locke C; Granneman GR; Sommerville KW
    Epilepsia; 1998 Aug; 39(8):868-73. PubMed ID: 9701378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Various Aspects of Tiagabine Effectiveness as Add-on Therapy in Patients with Refractory Epilepsy.
    Viteva E; Zahariev Z
    Folia Med (Plovdiv); 2020 Mar; 62(1):59-64. PubMed ID: 32337898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The short-term impact of adjunctive tiagabine on health-related quality of life.
    Cramer J; Ryan J; Chang J; Sommerville K;
    Epilepsia; 2001; 42 Suppl 3():70-5. PubMed ID: 11520329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [An open study of tiagabine in partial epilepsy].
    Arroyo S; Salas-Puig J;
    Rev Neurol; 2001 Jun 1-15; 32(11):1041-6. PubMed ID: 11562825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy.
    Luszczki JJ; Czuczwar SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):529-38. PubMed ID: 17204358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of Gabitril and Lamictal for drug-resistant epilepsy in adults.
    Chmielewska B; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():35-42. PubMed ID: 11977339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of tiagabine with valproate in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves.
    Luszczki JJ; Krzyzanowski M; Swiader MJ
    Adv Med Sci; 2009; 54(1):75-81. PubMed ID: 19366650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria.
    Piccinelli P; Borgatti R; Perucca E; Tofani A; Donati G; Balottin U
    Epilepsia; 2000 Nov; 41(11):1485-8. PubMed ID: 11077464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.